Table 1.
Age | Sex | Days active [days/week] | PA guideline adherence | ST guideline adherence | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Pre (M ± s) | Peri (M ± s) | Peri–pre (diff. [95% CI], d) | Pre (%) | Peri (%) | Peri–pre (diff. [95% CI]) | Pre (%) | Peri (%) | Peri–pre (diff. [95% CI]) | ||
4–5 (n = 317) | m | 4.7 ± 1.8 | 5.6 ± 1.7 | + 0.9 [0.6, 1.2], 0.46** | 30.0 | 47.7 | + 17.7% [7.3, 27.5]** | 94.7 | 69.4 | − 25.3% [− 17.5, − 33.0]** |
f | 5.0 ± 1.8 | 5.6 ± 1.6 | + 0.6 [0.3, 0.9], 0.30** | 32.2 | 43.5 | + 11.4% [0.2, 22.1]* | 92.5 | 76.9 | − 15.6% [− 7.4, − 23.7]** | |
Ø | 4.8 ± 1.8 | 5.6 ± 1.6 | + 0.8 [0.5, 1.0], 0.39** | 31.0 | 45.7 | + 14.7% [7.2, 22.1] ** | 93.7 | 72.9 | − 20.1% [− 15.2, − 26.4]** | |
6–10 (n = 647) | m | 4.8 ± 1.7 | 5.2 ± 1.9 | + 0.4 [0.2, 0.7], 0.19** | 28.7 | 44.1 | + 15.4% [8.2, 22.4]** | 77.6 | 42.4 | − 35.5% [− 28.4, − 42.0]** |
f | 4.5 ± 1.7 | 5.1 ± 1.8 | + 0.6 [0.4, 0.8], 0.29** | 22.7 | 37.4 | + 14.8% [7.4, 21.8]** | 79.7 | 52.6 | − 27.1% [− 19.6, − 34.1]** | |
Ø | 4.7 ± 1.7 | 5.2 ± 1.9 | + 0.5 [0.3, 0.7], 0.24** | 25.9 | 41.0 | + 15.1% [10.0, 20.1]** | 78.6 | 47.1 | − 31.6% [− 26.5, − 36.4]** | |
11–13 (n = 343) | m | 4.0 ± 1.8 | 4.3 ± 2.0 | + 0.3 [0.0, 0.6], 0.15 | 15.2 | 23.5 | + 8.3% [− 0.2, 16.8] | 38.7 | 15.7 | − 23.0% [− 13.5, − 32.0]** |
f | 3.6 ± 1.6 | 3.8 ± 2.0 | + 0.3 [− 0.1, 0.6], 0.13 | 6.9 | 14.1 | + 7.2% [0.8, 13.8]* | 41.4 | 17.0 | − 24.3% [− 14.9, − 33.2]** | |
Ø | 3.8 ± 1.7 | 4.1 ± 2.0 | + 0.3 [0.1, 0.5], 0.14* | 10.9 | 18.7 | + 7.7% [2.4, 13.1]* | 40.1 | 16.4 | − 23.7% [− 17.0, − 30.1]** | |
14–17 (n = 404) | m | 3.7 ± 1.6 | 3.7 ± 1.8 | + 0.1 [− 0.3, 0.4], 0.02 | 5.7 | 11.2 | + 5.6% [− 0.3, 11.6] | 15.3 | 7.3 | − 8.3% [− 1.4, − 14.8]* |
f | 3.5 ± 1.6 | 3.9 ± 1.8 | + 0.4 [0.2, 0.7], 0.22** | 5.9 | 9.7 | + 3.9% [− 1.2, 9.0] | 30.8 | 16.8 | − 14.0% [− 6.1, − 21.7]** | |
Ø | 3.6 ± 1.6 | 3.8 ± 1.8 | + 0.3 [0.1, 0.5], 0.13* | 5.8 | 10.4 | + 4.8% [0.9, 8.5]* | 23.9 | 12.6 | − 11.3% [− 6.0, − 16.6]** | |
4–17 (n = 1711) | m | 4.4 ± 1.8 | 4.8 ± 2.0 | + 0.4 [0.3, 0.6], 0.20** | 21.4 | 34.0 | + 12.5% [8.2, 16.6]** | 60.7 | 35.2 | − 25.5% [− 20.8, − 30.0]** |
f | 4.1 ± 1.8 | 4.6 ± 1.9 | + 0.5 [0.3, 0.6], 0.24** | 16.4 | 26.3 | + 9.5% [4.5, 13.3]** | 61.1 | 40.0 | − 21.1% [− 16.4, − 25.7]** | |
Ø | 4.3 ± 1.8 | 4.7 ± 2.0 | + 0.4 [0.4, 0.5], 0.22** | 19.1 | 30.2 | + 11.1% [8.2, 13.9]** | 60.9 | 37.6 | − 23.3% [− 20.0, − 26.5]** |
PA guideline adherence: being physically active for 60 min or more a day during a normal week; ST guideline adherence: Using recreational screen time media for 120 min or less a day during a normal week.
m male, f female, Ø mean of males and females, M mean, s standard deviation, diff. difference peri-pre, 95% CI 95% confidence interval, d effect size Cohen’s d.
*/**Significant difference (*p < .05; **p < .01).